Latest Announcements

BSE & NSE corporate filings with AI summaries

NSEInvestor Presentation▲ PositiveResults5d ago

Mankind Pharma Limited

Investor Presentation

Mankind Pharma Limited has announced its Q1 FY27 financial results, showing a 12.9% YoY growth in revenue from operations, with domestic business (ex-CH) growing 11.0% YoY and exports business growing 29.0% YoY. The company has also reported a 16.5% YoY growth in gross profit and a 24.7% YoY growth in EBITDA.

Read more →📎 1 attachment
NSEGeneral Updates▲ PositiveResults5d ago

Colgate Palmolive (India) Limited

General Updates

Colgate-Palmolive (India) Limited has announced its unaudited financial results for the quarter ended June 30, 2026, with a net sales growth of 12% and a net profit growth of 11% excluding one-offs and exceptional items. The company has also won several awards for its innovative campaigns and sustainability initiatives.

Read more →📎 1 attachment
NSEPress Release▲ PositiveResults5d ago

Swiggy Limited

Press Release

Swiggy Limited reported its unaudited financial results for the quarter ended June 30, 2026, with revenue growing 34.0% YoY to INR 7,112 Cr, and Adjusted EBITDA improving by INR 100 Cr YoY to INR 292 Cr. The company's Food Delivery business Gross Order Value (GOV) grew 17.4% YoY, and Quick Commerce hit contribution breakeven in May '26.

Read more →📎 1 attachment
NSEOutcome of Board MeetingResults5d ago

Global Health Limited

Outcome of Board Meeting

Global Health Limited has submitted its unaudited financial results for the first quarter ended June 30, 2026, and announced the approval of the results by its Board of Directors. The company also declared a final dividend of ₹0.50 per equity share for the financial year 2025-26, subject to shareholder approval at the upcoming Annual General Meeting.

Read more →📎 1 attachment
BSECompany UpdateResults5d ago

Mankind Pharma Ltd

Board of Directors of the Company in its meeting held today has inter-alia considered and approved the issuance of corproate guarantee in favour of Bharat Serums & Vaccines Limited, a WOS.

Mankind Pharma Ltd's board of directors has approved the issuance of a corporate guarantee in favor of Bharat Serums & Vaccines Limited, a wholly-owned subsidiary, and has also considered and approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026.

Read more →📎 1 attachment
NSEGeneral Updates▲ PositiveResults5d ago

Swiggy Limited

General Updates

Swiggy Limited has informed the Exchange about the Shareholders Letter dated July 30, 2026, announcing the company's Q1 FY27 financial results, including a Contribution margin break-even in Quick Commerce and a 39.8% YoY growth in GOV.

Read more →📎 1 attachment
BSEBoard MeetingResults5d ago

Global Health Ltd

Outcome of Board Meeting held today i.e. July 30, 2026, to consider Unaudited Financial Results for Quarter ended June 30, 2026.

Global Health Ltd's board meeting outcome announced unaudited financial results for Q1 FY2026, approved revised construction plan for Guwahati hospital, and appointed Chief Digital Officer. The company also declared a final dividend of Rs. 0.50 per equity share for FY2025-26, subject to shareholder approval.

Read more →📎 1 attachment
BSEAGM/EGMResults5d ago

Aditya Birla Money Ltd-$

30th Annual General Meeting of the Company was held today (30th July 2026, Thursday) at 12:00 Noon and concluded at 12:53 PM through Video Conferencing and Other Audio Visual Means in compliance ....

Aditya Birla Money Ltd held its 30th Annual General Meeting on July 30, 2026, through video conferencing. The meeting adopted the audited financial statements for the year ended March 31, 2026, and re-appointed Mr. Gopi Krishna Tulsian as a non-executive director. The company also increased its authorized share capital and altered its Memorandum of Association.

Read more →📎 1 attachment
NSEOutcome of Board MeetingResults5d ago

Swiggy Limited

Outcome of Board Meeting

Swiggy Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, with a net loss of ₹1 crore and a total comprehensive loss of ₹1 crore. The results were approved by the Board of Directors and reviewed by the independent auditor Walker Chandiok & Co LLP.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults5d ago

Bajaj Finance Ltd

Investor Presentation for the Quarter ended 30 June 2026

Bajaj Finance Ltd has announced its Q1 FY27 investor presentation, highlighting excellent quarter performance across key metrics. AUM grew by 24% to ₹ 546,944 crore, with new customer additions and credit costs improving. The company expects to disburse 60-62 MM new loans in FY27 and add 18-20 MM new customers to its franchise.

Read more →📎 1 attachment
← PreviousPage 304 of 861Next →